ClinicalTrials.govpublic full text
Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
irritable bowel syndrome, abdominal pain, olorinab, apd371, irritable bowel syndrome (ibs), ibs-c (ibs with predominant constipation), ibs-d (ibs with predominant diarrhea), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831380
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.